ASO Author Reflections: Defining the Role of PIPAC in the Treatment of Peritoneal Metastases

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, City of Hope Cancer Center, Duarte, CA, USA. Mraoof@coh.org.
² Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. tdellinger@coh.org.

Comment

Mustafa Raoof et al. Ann Surg Oncol. 2022 Jan.

. 2022 Jan;29(1):186-187.

doi: 10.1245/s10434-021-10548-3. Epub 2021 Jul 26.

¹ Division of Surgical Oncology, Department of Surgery, City of Hope Cancer Center, Duarte, CA, USA. Mraoof@coh.org.
² Division of Gynecologic Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. tdellinger@coh.org.

No abstract available

Comment on

PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.
Raoof M, Malhotra G, Kohut A, O'Leary M, Frankel P, Tran T, Fakih M, Chao J, Lim D, Woo Y, Paz IB, Lew M, Cristea MC, Rodriguez-Rodriguez L, Fong Y, Blakely A, Whelan R, Reymond MA, Merchea A, Dellinger TH. Raoof M, et al. Ann Surg Oncol. 2022 Jan;29(1):175-185. doi: 10.1245/s10434-021-10505-0. Epub 2021 Aug 13. Ann Surg Oncol. 2022. PMID: 34387765 Clinical Trial.

1. Quénet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256–66. - DOI
1. van Driel WJ, Koole SN, Sonke GS. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med. 2018;378(14):1363–4. https://doi.org/10.1056/NEJMc1802033 . - DOI - PubMed
1. Alyami M, Hübner M, Grass F, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20(7):e368–77. https://doi.org/10.1016/S1470-2045(19)30318-3 . - DOI - PubMed
1. Raoof M, Malhotra G, Kohut A, et al. PIPAC for the treatment of gynecologic and gastrointestinal peritoneal metastases: technical and logistic considerations of a Phase 1 trial. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10505-0 .